Do not use on infected, actively bleeding, or severely damaged skin without medical advice
Cancer-related tissue damage BPC-157's angiogenic properties are a theoretical concern in the context of existing tumors
Longevity and anti-aging protocols For general anti-aging applications, the standard 5 mg daily for 20 days, repeated once or twice annually, represents the most validated approach
Some patients prefer morning administration to allow any mild nausea to resolve during the day, while others may prefer evening injection if they experience fatigue or other symptoms following administration
Second, it creates a record that helps troubleshoot if your results change unexpectedly mid-vial
Not every long COVID patient is an appropriate candidate for peptide therapy and that's okay